Publication Name	World Journal of Gastroenterology
Manuscript ID	102291
Country	Taiwan

Received	2024-10-14 00:08
Peer-Review Started	2024-10-14 00:08
To Make the First Decision
Return for Revision	2025-02-06 19:13
Revised	2025-03-01 01:48
Second Decision	2025-03-11 02:45
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2025-03-11 06:27
Articles in Press	2025-03-11 06:27
Publication Fee Transferred
Edit the Manuscript by Language Editor	2025-03-15 04:23
Typeset the Manuscript	2025-03-24 05:53
Publish the Manuscript Online	2025-04-02 10:54

ISSN	1007-9327 (print) and 2219-2840 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright	© The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Editorial
Article Title	Role of gut microbiota and mesenteric adipose tissue in the pathology of Crohn’s disease: Potential therapeutic targets
Manuscript Source	Invited Manuscript
All Author List	Han-Jung Liu, Meng-Che Wu and Shuo-Yan Gau
ORCID	Author(s) ORCID Number Shuo-Yan Gau http://orcid.org/0000-0001-8897-5635
Funding Agency and Grant Number
Corresponding Author	Shuo-Yan Gau, MD, Department and Graduate Institute of Business Administration, National Taiwan University, No. 1 Roosevelt Rd, Taipei 106319, Taiwan. sixsamurai.shien15@gmail.com
Key Words	Crohn's disease; Gut microbiota; Probiotics; Ulcerative colitis; Inflammatory bowel disease
Core Tip	This editorial highlights the role of the gut microbiota in inflammatory bowel disease (IBD), focusing on the potential of probiotics, fecal microbiota transplantation (FMT), and dietary strategies in managing IBD. The gut microbiota plays a crucial role in IBD. Probiotics show potential in ulcerative colitis (UC), but further research is needed for Crohn’s disease. FMT offers promise for UC, and personalized therapies targeting microbial imbalances may improve IBD management. Dietary approaches can aid in managing IBD symptoms, but patient adherence is essential. Clinicians and researchers should focus on the gut microbiota and personalized therapies for IBD.
Publish Date	2025-04-02 10:54
Citation	<p>Liu HJ, Wu MC, Gau SY. Role of gut microbiota and mesenteric adipose tissue in the pathology of Crohn’s disease: Potential therapeutic targets. <i>World J Gastroenterol</i> 2025; 31(13): 102291</p>
URL	https://www.wjgnet.com/1007-9327/full/v31/i13/102291.htm
DOI	https://dx.doi.org/10.3748/wjg.v31.i13.102291

Full Article (PDF)	WJG-31-102291-with-cover.pdf
Manuscript File	102291_Auto_Edited_031525.docx
Answering Reviewers	102291-answering-reviewers.pdf
Audio Core Tip	102291-audio.m4a
Conflict-of-Interest Disclosure Form	102291-conflict-of-interest-statement.pdf
Copyright License Agreement	102291-copyright-assignment.pdf
Non-Native Speakers of English Editing Certificate	102291-non-native-speakers.pdf
Peer-review Report	102291-peer-reviews.pdf
Scientific Misconduct Check	102291-scientific-misconduct-check.png
Scientific Editor Work List	102291-scientific-editor-work-list.pdf
CrossCheck Report	102291-crosscheck-report.pdf